PT - JOURNAL ARTICLE AU - Ciarmiello, Andrea AU - Tutino, Francesca AU - Giovannini, Elisabetta AU - Milano, Amalia AU - Barattini, Matteo AU - Yosifov, Nikola AU - Calvi, Debora AU - Setti, Maurizio AU - Sivori, Massimiliano AU - Sani, Cinzia AU - Bastreri, Andrea AU - Staffiere, Raffaele AU - Stefanini, Teseo AU - Artioli, Stefania AU - Giovacchini, Giampiero TI - Multivariable risk modelling and survival analysis with machine learning in SARS-CoV-2 infection AID - 10.1101/2023.06.22.23291773 DP - 2023 Jan 01 TA - medRxiv PG - 2023.06.22.23291773 4099 - http://medrxiv.org/content/early/2023/06/29/2023.06.22.23291773.short 4100 - http://medrxiv.org/content/early/2023/06/29/2023.06.22.23291773.full AB - Aim We evaluated the performance of a machine learning model based on demographic variables, blood tests, pre-existing comorbidities, and CT-based radiomic features to predict critical outcome in patients with acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Methods We retrospectively enrolled 694 SARS-CoV-2 positive patients. Clinical and demographic data were extracted from clinical records. Radiomic data were extracted from CT. Patients were randomized to the training (80%, n=556) or test (20%, n=138) dataset. The training set was used to define the association between severity of disease and comorbidities, laboratory tests, demographic and CT-based radiomic variables, and to implement a risk prediction model. Models were evaluated using the C statistic and Brier scores. The test set was used for external validation.Results Patients who died (n=157) were predominantly male (66%) over the age of 50 with (median [range] C-reactive protein (CRP)=5 [1, 37] mg/dL, lactate dehydrogenase (LDH)=494 [141, 3,631] U/I and D-dimer=6.006 [168, 152.015] ng/ml). Surviving patients (n=537) had (median [range]) CRP=3 [0, 27] mg/dL, LDH=484 [78, 3.745] U/I, and D-dimer=1.133 [96, 55.660]ng/ml. The strongest risk factors were D-dimer, age, and cardiovascular disease.The model implemented using the variables identified by the LASSO Cox regression analysis classified 152 of the 157 (97%) non-survivors as high risk individuals (Odd ratio=54.2 [21.9, 134.4]). Median survival in this group (14 [12, 19] days) was not different from that observed in non-survivors (12 [10, 14] days).Conclusions A machine learning model based on combined data available on the first days of hospitalization (demographics, CT-radiomics, comorbidities, and blood biomarkers), can identify SARS-CoV-2 patients at risk of serious illness and death.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures performed in studies involving human participants were in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Regional Review Committee granted ethical approval (CER Liguria: 251/2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.